Research ArticleResearch Letter
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable and Dean Schillinger
The Journal of the American Board of Family
Medicine May 2019, 32 (3) 418-423; DOI: https://doi.org/10.3122/jabfm.2019.03.180176
Christina Mangurian
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD, MASAishat Giwa
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MHIErin Brosey
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MSMartha Shumway
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
PhDJames Dilley
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MDElena Fuentes-Afflick
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD, MPHEliseo J. Pérez-Stable
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MDDean Schillinger
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MDReferences
- 1.↵
- 2.↵
- Brown S,
- Kim M,
- Mitchell C,
- Inskip H
- 3.↵
- Walker ER,
- McGee RE,
- Druss BG
- 4.↵
- Olfson M,
- Gerhard T,
- Huang C,
- Crystal S,
- Stroup TS
- 5.↵
- Lawrence D,
- Hancock KJ,
- Kisely S
- 6.↵
- Laursen TM,
- Nordentoft M,
- Mortensen PB
- 7.↵
- McEvoy JP,
- Meyer JM,
- Goff DC,
- et al
- 8.↵
- Newcomer JW,
- Hennekens CH
- 9.↵
- Mitchell AJ,
- Vancampfort D,
- Sweers K,
- van Winkel R,
- Yu W,
- De Hert M
- 10.↵
- Correll CU,
- Joffe BI,
- Rosen LM,
- Sullivan TB,
- Joffe RT
- 11.↵
- 12.↵
- Green AI,
- Lieberman JA,
- Hamer RM,
- et al
- 13.↵
- Kahn RS,
- Fleischhacker WW,
- Boter H,
- et al
- 14.↵
- Perez-Iglesias R,
- Mata I,
- Pelayo-Teran JM,
- et al
- 15.↵
- Oriot P,
- Feys JL,
- Mertens de Wilmars S,
- et al
- 16.↵
- Nasrallah HA,
- Meyer JM,
- Goff DC,
- et al
- 17.↵
- Smith DJ,
- Langan J,
- McLean G,
- Guthrie B,
- Mercer SW
- 18.↵
- 19.↵
- Citrome L,
- Volavka J
- 20.↵
- Parks J,
- Radke A.Q.,
- Mazade N.A.
- 21.↵
- 22.↵
- Daumit GL,
- Dickerson FB,
- Wang NY,
- et al
- 23.↵
- Buckley PF,
- Miller DD,
- Singer B,
- Arena J,
- Stirewalt EM
- 24.↵
- 25.↵
- 26.↵
- Mangurian C,
- Newcomer JW,
- Vittinghoff E,
- et al
- 27.↵
- 28.↵
- Parameswaran SG,
- Chang C,
- Swenson AK,
- Shumway M,
- Olfson M,
- Mangurian CV
- 29.↵
- 30.↵
- Olfson M,
- Marcus SC,
- Wilk J,
- West JC
- 31.↵
- 32.↵
- 33.↵
- Handelsman Y,
- Bloomgarden ZT,
- Grunberger G,
- et al
In this issue
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable, Dean Schillinger
The Journal of the American Board of Family
Medicine May 2019, 32 (3) 418-423; DOI: 10.3122/jabfm.2019.03.180176
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable, Dean Schillinger
The Journal of the American Board of Family
Medicine May 2019, 32 (3) 418-423; DOI: 10.3122/jabfm.2019.03.180176
Jump to section
Related Articles
- No related articles found.